MCA logo

PUBLIC PORTAL

MEDICALLY REVIEWED

Roche reports positive five-year survival outcomes for extensive-stage small cell lung cancer

small cell lung cancer roche

IMbrella A, an extension of the Phase III IMpower133 study, demonstrates the potential for a durable overall survival benefit with Tecentriq plus chemotherapy in extensive-stage small cell lung cancer (ES-SCLC)
IMbrella A data build on the previously reported IMpower133 trial, which was the first clinically meaningful advance in . . .

Sign Up or Log In as a healthcare professional to read the full article.

Share via

Also worth reading

People also read:

Allergy medical center
Understanding and Managing Airborne Allergies

This article provides an overview of different types of allergies in Southeast Asia, including pollen, food, dust mite, insect sting, and mold allergies. It discusses the prevalence of each allergy in different countries, symptoms, and management options. The article aims to help readers understand and manage their allergies for a better quality of life.

Read More »